Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2013

01.11.2013 | Glaucoma

Global rates of glaucoma surgery

verfasst von: Kaweh Mansouri, Felipe A. Medeiros, Robert N. Weinreb

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To estimate global rates of glaucoma surgery.

Methods

National glaucoma and national ophthalmology societies were contacted to obtain rates of glaucoma surgery for the preceding 5 years. In countries without a professional society, leading ophthalmologists or non-governmental organizations (NGO) were approached. When available, published literature was used for the estimates. Three levels of evidence were assigned: published data from central government or insurance registries (level I), estimates provided by a national professional society based on survey of members (level II), and estimates based on data from individual glaucoma surgeons (level III). Glaucoma surgical rate (GSR) was defined as the annual number of total glaucoma surgeries performed per million population. Linear regression analysis was performed between GSR and the following parameters: population per ophthalmologist, per capita gross domestic product (GDP), and per capita health expenditures.

Results

Seventy-three glaucoma societies, 35 ophthalmology societies, as well as six NGOs and 37 leading ophthalmologists (11 other countries) were contacted. Data were obtained from 38 countries (10 level I, 23 level II, and 5 lev el III) with a total population of 1.723 billion. The average GSR was 139.2 ± 113.1 (range, 2.9–500.0). There was a positive correlation between GSR and GDP (r2 = 0.309, P = 0.0004) and GSR and the number of ophthalmologists (r2 = 0.476, P < 0.0001).

Conclusion

There is a paucity of data on rates of glaucoma surgery, particularly from developing countries. The new metric GSR may be useful for the allocation of healthcare resources, as well as for planning and monitoring public health interventions in glaucoma.
Literatur
1.
Zurück zum Zitat Pascolini D, Mariotti SP (2012) Global estimates of visual impairment: 2010. Br J Ophthalmol 96:614–618PubMedCrossRef Pascolini D, Mariotti SP (2012) Global estimates of visual impairment: 2010. Br J Ophthalmol 96:614–618PubMedCrossRef
3.
Zurück zum Zitat Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844–851PubMed Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844–851PubMed
4.
Zurück zum Zitat Kroese M, Burton H (2003) Primary open angle glaucoma. The need for a consensus case definition. J Epidemiol Community Health 57:752–754PubMedCrossRef Kroese M, Burton H (2003) Primary open angle glaucoma. The need for a consensus case definition. J Epidemiol Community Health 57:752–754PubMedCrossRef
5.
7.
Zurück zum Zitat Schmier JK, Covert DW, Lau EC, Robin AL (2009) Trends in annual Medicare expenditures for glaucoma surgical procedures from 1997 to 2006. Arch Ophthalmol 127:900–905PubMedCrossRef Schmier JK, Covert DW, Lau EC, Robin AL (2009) Trends in annual Medicare expenditures for glaucoma surgical procedures from 1997 to 2006. Arch Ophthalmol 127:900–905PubMedCrossRef
8.
Zurück zum Zitat Walland MJ (2004) Glaucoma treatment in Australia: changing patterns of therapy 1994–2003. Clin Experiment Ophthalmol 32:590–596PubMedCrossRef Walland MJ (2004) Glaucoma treatment in Australia: changing patterns of therapy 1994–2003. Clin Experiment Ophthalmol 32:590–596PubMedCrossRef
9.
Zurück zum Zitat Baudouin C, Rouland JF, Le Pen C (2003) Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France. Eur J Ophthalmol 13(Suppl 4):S53–S60PubMed Baudouin C, Rouland JF, Le Pen C (2003) Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France. Eur J Ophthalmol 13(Suppl 4):S53–S60PubMed
10.
Zurück zum Zitat van der Valk R, Schouten JS, Webers CA, Beckers HJ, van Amelsvoort LG, Schouten HJ, Hendrikse F, Prins MH (2005) The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries. J Glaucoma 14:239–242PubMedCrossRef van der Valk R, Schouten JS, Webers CA, Beckers HJ, van Amelsvoort LG, Schouten HJ, Hendrikse F, Prins MH (2005) The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries. J Glaucoma 14:239–242PubMedCrossRef
11.
Zurück zum Zitat Rachmiel R, Trope GE, Chipman ML, Gouws P, Buys YM (2006) Effect of medical therapy on glaucoma filtration surgery rates in Ontario. Arch Ophthalmol 124:1472–1477PubMedCrossRef Rachmiel R, Trope GE, Chipman ML, Gouws P, Buys YM (2006) Effect of medical therapy on glaucoma filtration surgery rates in Ontario. Arch Ophthalmol 124:1472–1477PubMedCrossRef
12.
Zurück zum Zitat Keenan TD, Salmon JF, Yeates D, Goldacre MJ (2009) Trends in rates of trabeculectomy in England. Eye (Lond) 23:1141–1149CrossRef Keenan TD, Salmon JF, Yeates D, Goldacre MJ (2009) Trends in rates of trabeculectomy in England. Eye (Lond) 23:1141–1149CrossRef
13.
Zurück zum Zitat Thomas R, Sekhar GC, Kumar RS (2004) Glaucoma management in developing countries: medical, laser, and surgical options for glaucoma management in countries with limited resources. Curr Opin Ophthalmol 15:127–131PubMedCrossRef Thomas R, Sekhar GC, Kumar RS (2004) Glaucoma management in developing countries: medical, laser, and surgical options for glaucoma management in countries with limited resources. Curr Opin Ophthalmol 15:127–131PubMedCrossRef
14.
Zurück zum Zitat United Nations Department of Economic and Social Affairs PD (2009) World population prospects: the 2008 revision (advanced Excel tables). United Nations, New York United Nations Department of Economic and Social Affairs PD (2009) World population prospects: the 2008 revision (advanced Excel tables). United Nations, New York
15.
Zurück zum Zitat Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya’ale D, Negrel AD, Resnikoff S (2004) 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 11:67–115PubMedCrossRef Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya’ale D, Negrel AD, Resnikoff S (2004) 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 11:67–115PubMedCrossRef
16.
Zurück zum Zitat Campbell RJ, Trope GE, Rachmiel R, Buys YM (2008) Glaucoma laser and surgical procedure rates in Canada: a long-term profile. Can J Ophthalmol 43:449–453PubMedCrossRef Campbell RJ, Trope GE, Rachmiel R, Buys YM (2008) Glaucoma laser and surgical procedure rates in Canada: a long-term profile. Can J Ophthalmol 43:449–453PubMedCrossRef
17.
Zurück zum Zitat Fraser SG, Wormald RP (2008) Hospital episode statistics and changing trends in glaucoma surgery. Eye (Lond) 22:3–7CrossRef Fraser SG, Wormald RP (2008) Hospital episode statistics and changing trends in glaucoma surgery. Eye (Lond) 22:3–7CrossRef
18.
Zurück zum Zitat Wishart PK (2009) Interpretation of the glaucoma “landmark studies”. Br J Ophthalmol 93:561–562PubMedCrossRef Wishart PK (2009) Interpretation of the glaucoma “landmark studies”. Br J Ophthalmol 93:561–562PubMedCrossRef
19.
Zurück zum Zitat Mendrinos E, Mermoud A, Shaarawy T (2008) Nonpenetrating glaucoma surgery. Surv Ophthalmol 53:592–630PubMedCrossRef Mendrinos E, Mermoud A, Shaarawy T (2008) Nonpenetrating glaucoma surgery. Surv Ophthalmol 53:592–630PubMedCrossRef
20.
Zurück zum Zitat Shaarawy T, Mansouri K, Schnyder C, Ravinet E, Achache F, Mermoud A (2004) Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 30:1225–1231PubMedCrossRef Shaarawy T, Mansouri K, Schnyder C, Ravinet E, Achache F, Mermoud A (2004) Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 30:1225–1231PubMedCrossRef
21.
Zurück zum Zitat Mansouri K, Shaarawy T, Wedrich A, Mermoud A (2006) Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial. J Glaucoma 15:264–270PubMedCrossRef Mansouri K, Shaarawy T, Wedrich A, Mermoud A (2006) Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial. J Glaucoma 15:264–270PubMedCrossRef
22.
Zurück zum Zitat Mansouri K, Mariani A, Ravinet E (2011) Reconditioning of the trabeculo-Descemet’s membrane with the 532-nm Nd : YAG (SLT) laser after deep sclerectomy. Eye (Lond) 25:1655–1657CrossRef Mansouri K, Mariani A, Ravinet E (2011) Reconditioning of the trabeculo-Descemet’s membrane with the 532-nm Nd : YAG (SLT) laser after deep sclerectomy. Eye (Lond) 25:1655–1657CrossRef
23.
Zurück zum Zitat Foster A (2001) Cataract and “Vision 2020—the right to sight” initiative. Br J Ophthalmol 85:635–637PubMedCrossRef Foster A (2001) Cataract and “Vision 2020—the right to sight” initiative. Br J Ophthalmol 85:635–637PubMedCrossRef
24.
Zurück zum Zitat Sommer A (2012) A simple metric can be a powerful tool for planning and advocacy. Arch Ophthalmol 130:1599–1600PubMedCrossRef Sommer A (2012) A simple metric can be a powerful tool for planning and advocacy. Arch Ophthalmol 130:1599–1600PubMedCrossRef
25.
Zurück zum Zitat Ntim-Amponsah CT, Amoaku WM, Ofosu-Amaah S, Ewusi RK, Idirisuriya-Khair R, Nyatepe-Coo E, Adu-Darko M (2004) Prevalence of glaucoma in an African population. Eye (Lond) 18:491–497CrossRef Ntim-Amponsah CT, Amoaku WM, Ofosu-Amaah S, Ewusi RK, Idirisuriya-Khair R, Nyatepe-Coo E, Adu-Darko M (2004) Prevalence of glaucoma in an African population. Eye (Lond) 18:491–497CrossRef
26.
Zurück zum Zitat Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73:115–121PubMed Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73:115–121PubMed
27.
Zurück zum Zitat Thylefors B, Negrel AD (1994) The global impact of glaucoma. Bull World Health Organ 72:323–326PubMed Thylefors B, Negrel AD (1994) The global impact of glaucoma. Bull World Health Organ 72:323–326PubMed
29.
Zurück zum Zitat Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262–267PubMedCrossRef Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262–267PubMedCrossRef
30.
Zurück zum Zitat Mansouri K, Orguel S, Mermoud A, Haefliger I, Flammer J, Ravinet E, Shaarawy T (2008) Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial. Br J Ophthalmol 92:332–336PubMedCrossRef Mansouri K, Orguel S, Mermoud A, Haefliger I, Flammer J, Ravinet E, Shaarawy T (2008) Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial. Br J Ophthalmol 92:332–336PubMedCrossRef
31.
Zurück zum Zitat Medeiros FA, Pinheiro A, Moura FC, Leal BC, Susanna R Jr (2002) Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther 18:489–498PubMedCrossRef Medeiros FA, Pinheiro A, Moura FC, Leal BC, Susanna R Jr (2002) Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther 18:489–498PubMedCrossRef
32.
Zurück zum Zitat King AJ, Stead RE, Rotchford AP (2011) Treating patients presenting with advanced glaucoma—should we reconsider current practice? Br J Ophthalmol 95:1185–1192PubMedCrossRef King AJ, Stead RE, Rotchford AP (2011) Treating patients presenting with advanced glaucoma—should we reconsider current practice? Br J Ophthalmol 95:1185–1192PubMedCrossRef
Metadaten
Titel
Global rates of glaucoma surgery
verfasst von
Kaweh Mansouri
Felipe A. Medeiros
Robert N. Weinreb
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 11/2013
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-013-2464-7

Weitere Artikel der Ausgabe 11/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.